Pulmonx Corp. (LUNG)
1.83
-0.05
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
1.82
-0.01
(-0.55%)
After-Hours: 20:00
Pulmonx Enterprise Value : 78.70M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 78.70M |
| October 22, 2026 | 80.85M |
| October 21, 2026 | 78.70M |
| October 20, 2026 | 78.27M |
| October 19, 2026 | 75.27M |
| October 16, 2026 | 76.56M |
| October 15, 2026 | 79.56M |
| October 14, 2026 | 76.56M |
| October 13, 2026 | 75.70M |
| October 12, 2026 | 77.42M |
| October 09, 2026 | 79.13M |
| October 08, 2026 | 77.85M |
| October 07, 2026 | 79.13M |
| October 06, 2026 | 76.56M |
| October 05, 2026 | 80.85M |
| October 02, 2026 | 78.70M |
| October 01, 2026 | 82.14M |
| September 30, 2026 | 82.14M |
| September 29, 2026 | 85.15M |
| September 28, 2026 | 84.29M |
| September 25, 2026 | 82.14M |
| September 24, 2026 | 81.71M |
| September 23, 2026 | 86.01M |
| September 22, 2026 | 88.58M |
| September 21, 2026 | 85.58M |
| Date | Value |
|---|---|
| September 18, 2026 | 89.01M |
| September 17, 2026 | 85.15M |
| September 16, 2026 | 83.86M |
| September 15, 2026 | 82.14M |
| September 14, 2026 | 84.72M |
| September 11, 2026 | 79.56M |
| September 10, 2026 | 79.56M |
| September 09, 2026 | 85.15M |
| September 08, 2026 | 89.44M |
| September 04, 2026 | 95.02M |
| September 03, 2026 | 97.17M |
| September 02, 2026 | 98.03M |
| September 01, 2026 | 96.31M |
| August 31, 2026 | 102.33M |
| August 28, 2026 | 102.33M |
| August 27, 2026 | 104.04M |
| August 26, 2026 | 107.48M |
| August 25, 2026 | 107.48M |
| August 24, 2026 | 98.03M |
| August 21, 2026 | 97.17M |
| August 20, 2026 | 98.89M |
| August 19, 2026 | 99.32M |
| August 18, 2026 | 97.17M |
| August 17, 2026 | 95.88M |
| August 14, 2026 | 104.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.08M |
| Revenue (Quarterly) | 22.76M |
| Total Expenses (Quarterly) | 32.84M |
| EPS Diluted (Quarterly) | -0.2374 |
| Gross Profit Margin (Quarterly) | 77.53% |
| Profit Margin (Quarterly) | -44.30% |
| Earnings Yield | -63.17% |
| Normalized Earnings Yield | -63.17 |